HYPOGLYCAEMIA FROM SULPHONYLUREA

被引：3
|
作者：
DALL, JLC
MELROSE, AG
机构：
来源：
BRITISH MEDICAL JOURNAL | 1964年 / 1卷 / 539期
关键词：
D O I：
10.1136/bmj.1.5394.1379
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1379 / &
相关论文
共 50 条
  • [31] Sitagliptin provides similar glycaemic improvement with less hypoglycaemia in the elderly with type 2 diabetes mellitus compared to sulphonylurea
    Shankar, R.
    Engel, S. S.
    Xu, L.
    Golm, G. T.
    Davies, M. J.
    Kaufman, K. D.
    Goldstein, B. J.
    DIABETOLOGIA, 2012, 55 : S344 - S345
  • [32] The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: a randomised trial
    Al Sifri, S.
    Basiounny, A.
    Echtay, A.
    Al Omari, M.
    Harman-Boehm, I.
    Kaddaha, G.
    Al Tayeb, K.
    Mahfouz, A. S.
    Al Elq, A.
    Radican, L.
    Oezesen, C.
    Katzeff, H. L.
    Musser, B. J.
    Suryawanshi, S.
    Girman, C. J.
    Davies, M. J.
    Engel, S. S.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2011, 65 (11) : 1132 - 1140
  • [33] Comparing hormonal and symptomatic responses to experimental hypoglycaemia in insulin- and sulphonylurea-treated Type 2 diabetes
    Choudhary, P.
    Lonnen, K.
    Emery, C. J.
    MacDonald, I. A.
    MacLeod, K. M.
    Amiel, S. A.
    Heller, S. R.
    DIABETIC MEDICINE, 2009, 26 (07) : 665 - 672
  • [34] Counter regulatory hormone responses to hypoglycaemia in subjects with type 2 diabetes mellitus: a comparison of treatment with insulin, metformin or sulphonylurea
    S. Hoashi
    B. Wade
    M. Kilbane
    D. Cannon
    B. T. Kinsley
    Irish Journal of Medical Science, 2002, 171 (Suppl 5) : 17 - 17
  • [35] HYPOGLYCAEMIA FROM SULPHONYLUREAS
    不详
    BMJ-BRITISH MEDICAL JOURNAL, 1964, 1 (538): : 996 - +
  • [36] Association between CYP2C9 slow metabolizer genotypes and severe hypoglycaemia on medication with sulphonylurea hypoglycaemic agents
    Holstein, A
    Plaschke, A
    Ptak, M
    Egberts, EH
    El-Din, J
    Brockmöller, J
    Kirchheiner, J
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 60 (01) : 103 - 106
  • [37] FACTORS ASSOCIATED WITH WEIGHT GAIN AND HYPOGLYCAEMIA AND THE IMPACT UPON HOSPITALISATION IN TYPE 2 DIABETES PATIENTS MANAGED WITH METFORMIN PLUS SULPHONYLUREA
    McEwan, P.
    Gordon, J.
    Evans, M.
    Puelles, J.
    VALUE IN HEALTH, 2014, 17 (07) : A360 - A360
  • [38] Hypoglycaemia in sulphonylurea-treated subjects with type 2 diabetes undergoing Ramadan fasting: a five-country observational study
    Aravind, S. R.
    Al Tayeb, Khaled
    Ismail, Shaiful Bahari
    Shehadeh, Naim
    Kaddaha, Ghaida
    Liu, Rose
    Balshaw, Robert
    Lesnikova, Nadia
    Heisel, Olaf
    Girman, Cynthia J.
    Musser, Bret J.
    Davies, Michael J.
    Katzeff, Harvey L.
    Engel, Samuel S.
    Radican, Larry
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (06) : 1237 - 1242
  • [39] Risk of hypoglycaemia in users of sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite group: population based cohort study
    van Dalem, Judith
    Brouwers, Martijn C. G. J.
    Stehouwer, Coen D. A.
    Krings, Andre
    Leufkens, Hubert G. M.
    Driessen, Johanna H. M.
    de Vries, Frank
    Burden, Andrea M.
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 354
  • [40] The role of sulphonylurea in combination therapy assessed in a trial of sulphonylurea withdrawal
    Landstedt-Hallin, L
    Arner, P
    Lins, PE
    Bolinder, J
    Olsen, H
    Groop, L
    DIABETIC MEDICINE, 1999, 16 (10) : 827 - 834
12345